News
Make Kidney Cancer Treatment Priority- Kidney Cancer UK
NICE, the National Institute for Health and Care Excellence, has received a plea from the Kidney Cancer UK to bring about guidelines on the...
Drug Research
Revenue Clawback Rate Increase Warned By ABPI In The UK
The Association of the British Pharmaceutical Industry (ABPI) has urged the government to take prompt action in response to the planned UK statutory revenue...
Clinical Trials
Endometrial Cancer Survival Is An Enhanced Possibility
A Phase III trial found that pembrolizumab plus chemotherapy enhanced survival in endometrial cancer patients.
A Phase III clinical trial comparing pembrolizumab to chemotherapy (carboplatin...
IT & Data Management
The ePI Deconstructed – A New Frontier in Patient Communication
Pharma manufacturers face several challenges when it comes to labels, both in terms of design and production. As the label size tends to increase...
Press Releases
RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced a significant milestone: they have de-risked over 1000...
Press Releases
Berry to Support Asia’s Growing Healthcare Market with New Facility, Center of Excellence in Bangalore, India
Berry Global Group, Inc., a leader in the design, development, and production of patient-centered healthcare solutions, will begin product production at its second manufacturing...
Articles
What are some of the key challenges Pharma has faced in 2022? Will these continue into 2023?
As 2023 takes over, there is a lot of hope that makes us cling to the pharmaceutical sector: a hope of getting novel ideas...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read